Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 242890

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : October | Volume : 16 | Issue : 10 | Page : DC11 - DC15 Full Version

Mycological Profile in Otomycosis Patients and their Drug Sensitivity: A Cross-sectional Study at Union Territory of Puducherry, India


Published: October 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/57715.17073
Anusheela Howlader, Prithiviraj Nagarajan, Latha Ragunathan

1. Assistant Professor, Department of Microbiology, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission’s Research Foundation (Deemed to be University), Kirumampakkam, Puducherry, India. 2. Assistant Professor (Research), Multi-Disciplinary Centre for Biomedical Research, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission’s Research Foundation (Deemed to be University), Kirumampakkam, Puducherry, India. 3. Professor and Head, Department of Microbiology, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission’s Research Foundation (Deemed to be University), Kirumampakkam, Puducherry, India.

Correspondence Address :
Dr. Prithiviraj Nagarajan,
Assistant Professor (Research), Multi-Disciplinary Centre for Biomedical Research, Aarupadai Veedu Medical College and Hospital, Vinayaka Mission’s Research Foundation, (Deemed to be University), Kirumampakkam, Puducherry-607403, India.
E-mail: prithivinaga@gmail.com

Abstract

Introduction: In clinical Otorhinolaryngology practice, otomycosis is a common problem to overcome caused by Aspergillus and Candida species. Although, we come across many difficulties to diagnose and treat otomycosis infections, many patients show drug resistance to antifungal agents with a high prevalence rate.

Aim: To elucidate the pattern of mycological agents and susceptibility testing of fungal species in samples collected from patients with an ear infection at a tertiary hospital.

Materials and Methods: The present hospital-based crosssectional study conducted in the Department of Microbiology and Department of Ear, Nose, and Throat (ENT) at Aarupadai Veedu Medical College and Hospital, Puducherry, India, from August 2018 to January 2020. A total of 126 samples were collected, transported and analysed for bacteriological and mycological analysis using direct inspection and culture techniques. By using the disc diffusion technique, the antifungal susceptibility testing was carried out to determine the sensitivity and resistance against ketoconazole, itraconazole, fluconazole, and amphotericin B. Data were analysed in terms of frequency using the Statistical Package for the Social Sciences (SPSS) software 25.0 version.

Results: Out of 126 samples, fungal isolates were 92, out of which the most common fungal isolate was Aspergillus niger followed by A. flavus, Candida albicans (C. albicans), A. terreus, and A. fumigatus. Also, the major common bacterial isolates were Staphylococcus aureus followed by Pseudomonas, Proteus, Escherichia coli (E. coli), and Klebsiella spp. Prevalence in males (58.73%) was more as compared to the females (41.27%), and itching was the most common presenting symptom. Otomycosis in Chronic Suppurative Otitis Media (CSOM) mainly affected males (40%) and is common in middle-aged groups (20-35 years) of outdoor and indoor workers, housewives and farmers, particularly during the monsoon season. Antifungal susceptibility testing of A. flavus and A. niger isolates revealed high sensitivity to amphotericin B, itraconazole and ketoconazole drugs but low efficacy to fluconazole drugs.

Conclusion: Otomycosis should be suspected clinically to prevent the unnecessary use of antibiotics. A high incidence of otomycosis has been encountered in many tropical countries. In present study, Aspergillus spp. and Candida spp. were the commonest fungal isolates in otomycosis. In our community, currently two drugs, amphotericin B and ketoconazole are the most frequently used for fungal infection. Properly identifying fungal agents and host factors involved in otomycosis can improve such patients’ outcomes.

Keywords

Antifungal drugs, Antifungal susceptibility testing, Fungal infection, Predisposing factors

In otorhinolaryngology outpatients, otomycosis is a common external ear canal fungal infection caused by a perforated tympanic membrane (1). Some of the symptoms are inflammation, itching, scaling, a hole in the tympanic membrane, hearing loss and discharge from the ear (2). The otomycosis frequency depends on the tropical and subtropical climatic conditions with hot, humid regions (as high as 54%) and dusty areas (3),(4). Otomycosis is a common medical problem and a health hazard in India (2),(4). There are numerous predisposing factors for otomycosis, which may be systemic or local; several predisposing factors, such as increased and indiscriminate use of topical antibiotics, instillation of hot oil/water in the ear, unhygienic mopping of the ear, use of hearing aids, swimming in contaminated water, cytotoxic chemotherapies and immunosuppressive diseases, etc., have increased the incidence of otomycosis (1),(4).

Fungi can either be the primary pathogen or be superimposed on bacterial infections (5). A wide range of fungi causes otomycosis, but Aspergillus and Candida species are the most common types of fungi that cause it (4). Aspergillus alone accounts for 75% of cases, with A. niger being the most common, followed by A. flavus and A. fumigatus (6). As a secondary contaminant in instances of external otitis, the fungus may be associated with bacterial infections (7). In most cases, the infection is unilateral and is characterised by inflammatory pruritis, scaling, and otalgia (8). Local debridement, local and systemic antifungal medications and stopping of topical antibiotics have been recommended as treatments. Otomycosis may sometimes be difficult to manage in terms of long-term care and follow-up, despite its recurrence rate being high (9).

However, information on otomycosis is still limited in the rural and tertiary populations (4). Yet, no proper systematic studies have been documented to identify otomycosis in the union territory of Puducherry’s geographical area. Therefore, the present study aimed to elucidate the pattern of mycological agents and their susceptibility testing from patients with an ear infection at a tertiary care hospital.

Material and Methods

The present study was a hospital-based cross-sectional study conducted from August 2018 to January 2020 in the Department of Microbiology and the Department of ENT at Aarupadai Veedu Medical College and Hospital, Puducherry, India. A total of 126 samples were collected (74 males and 52 females) aged between 10-60 years of the suspected fungus-infected patients during the study period. The patients from Aarupadai Veedu Medical College and Hospital were properly informed about the study and got individual consent from each patient before taking an ear swab. The study was duly approved by Institutional Ethics Committee (IEC) (IEC approval no:AV/IEC/2018/109).

Inclusion criteria: Otomycosis patients with symptoms like inflammation, itching, scaling, a hole in the tympanic membrane, hearing loss, ear discharge., dry matted masses of hyphae or white cheesy material, and those who gave their written consent, were included from the study.

Exclusion criteria: Patients with other ear problems, such as those with perforated tympanic membrane and chronic otitis media, who had recently been treated for otomycosis, and the patients who refused to give their consent forms were excluded from the study.

Study Procedure

Sample collection: Ear examination was done using an otoscope, and samples were collected by sterilising with 70% alcohol from the outside of the ear canal with two sterile cotton swabs under aseptic conditions. The collected specimens were immediately transferred to the Department of Microbiology. To diagnose otomycosis, a detailed history of patients were recorded on predetermined proforma and their clinical examination was done, otoscopic findings, and laboratory identification of fungus were also recorded (10).

Culture processing and identification: After cleaning the ear with spirit two ear swabs were collected aseptically, without touching the surroundings and directly inserting the swab into the ear canal; one ear swab was used for direct microscopy {(Gram’s staining, 10% Potassium hydroxide (KOH) wet mount)} to identify yeast-like fungi, and 10% KOH mount, Lacto Phenol Cotton Blue (LPCB) were used to identify filamentous fungi. The second swab was used for the purpose of the mycological and bacteriological cultures. For fungus culture, Sabouraud’s Dextrose Agar (SDA) with antibiotic gentamicin 50 ug/mL (HiMedia, India) was used as it is a common medium, which was incubated at 37°C and 25°C for two to three weeks (11). Candida isolates were morphologically recognised by gram stain, cultural characteristics, germ tube and chlamydospore development and inoculated on HiChrome agar (HiMedia, India) for species identification (12).

Antifungal susceptibility testing: The disc diffusion assay was performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines (M44-A2-method for antifungal disk diffusion susceptibility testing of yeast) to determine the susceptibility of Candida isolates (13). Mueller-Hinton Agar (MHA) was supplemented with 2% glucose and 0.5 mg/L methylene blue. The inoculum was taken with a sterile swab from SDA tubes and was standardised to 0.5 McFarland, lawn culture was done on MHA plates with 2% glucose and 0.5% methylene blue and antifungal drug discs itraconazole, fluconazole, ketoconazole and amphotericin B were applied and incubated at 37°C for 24 hours of incubation for proper growth (7). For the filamentous fungi CLSI guideline (M51-A-Method for antifungal disk diffusion susceptibility testing of non dermatophyte filamentous fungi) was followed (13).

Statistical Analysis

Statistical analysis was done using the one-way Analysis of Variance (ANOVA) method and a p-value of <0.05 was taken as significant. For the antibiotic sensitivity test, data were extracted and converted to an excel sheet, and data were analysed in terms of frequency using the SPSS 25.0 version.

Results

Demographic profile of patients: A total of 126 cases that fulfilled the inclusion criteria were included in this study. The majority of them were 52 (41.27%) females and 74 (58.73%) were males. In present study, otomycosis was frequently observed in all age groups. The most prevalent age group was 16-30 years while few numbers of the patients were reported in the paediatric age group of 0-15 years and above 60 years (Table/Fig 1). In the seasonal variation, the monsoon showed the highest incidence of otomycosis in the month of October 19 (15.08%) and September 18 (14.29%) (Table/Fig 2). Occupationally maximum number of patients were seen in indoor workers 46 (36.51%) followed by housewives and housemaids 37 (29.37%), while minimum cases were seen in other groups of outdoor (mechanics, drivers, shopkeepers, welding, handcraft workers and teachers) workers and agricultural workers (Table/Fig 1). The common presenting symptoms solely or in combination encountered in the study group have been summarised in (Table/Fig 3). Age group (years) Male Female Total (%) 0-15 3 2 5 (3.97) 16-30 29 19 48 (38.1)31-45 23 16 39 (30.95) 46-60 16 13 29 (23.01) Above 60 3 2 5 (3.97) Total 74 (58.73%) 52 (41.27%) 126 Occupation-wise distribution Occupation Total (%) Miscellaneous indoor worker 46 (36.51) Housewife and housemaid 37 (29.37) Labour (Mechanic, drivers, shopkeepers, welding, handcraft workers and teachers). 26 (20.63) Agriculturists 17 (13.49) (Table/Fig 1): Age, sex and occupation distribution of the otomycosis patients (N=126). (Table/Fig 3): Symptoms of otomycosis patients (N=126). (Table/Fig 2): Month-wise prevalence of otomycosis (N=126).

Laterality distribution of otomycosis patients: In the present study, total 8 (6.35%) cases represented as bilateral infection among that three cases were immunocompromised individuals. Among unilateral cases, the maximum number of otomycosis cases recorded in the right side ear showed predominantly 62 (49.2%) compared to the left ear at 56 (44.4%) (Table/Fig 4).

Common predisposing factors: In the present study, common predisposing factors noted were CSOM 37(29.37%) followed by CSOM with ear drops 28 (22.22%), Diabetes Mellitus (DM) with CSOM 11 (8.73%), Bathing in a pond 9 (7.14%), 30 (23.81%) of cases had no predisposing factors. The predisposing factors of various data for otomycosis are represented in (Table/Fig 5). Out of 126 samples only 92 (73.02%) were positive for the presence of fungal elements, 34 (26.98%) were negative both by microscopy and culture process.

Microbiological findings: Out of 126 specimens collected, 92 (73.02%) were positive for fungal growth by culture. The most common fungal isolates belonged to the species of Aspergillus. The
(Table/Fig 6) shows Aspergillus, Candida and gram positive and gram negative isolates.

Antifungal susceptibility testing (AST): The efficacy of antifungals against different species of cultures were tested such as amphotericin B, fluconazole, ketoconazole, and itraconazole (Table/Fig 7). The maximum (100%) resistance was seen in A. terreus when treated with amphotericin B, followed by A. niger (19.6%) and A. flavus (17.39%). The highest percentage of sensitivity among mold was observed with amphotericin B. A. fumigatus, C. parapsilosis, C. albicans, C. glabrata, Pencillium were sensitive to fluconazole and amphotericin B and itraconazole showed the maximum resistance against A. fumigatus (20%) followed by A. niger (6.5%) and A. flavus (4.3%). The other antifungal ketoconazole showed a relatively good effect against Candida species, as it was resistant at 16.7%.

Discussion

One of the most common external auditory canal fungal infection is otomycosis, often known as fungal otitis externa (1). Tropical and subtropical regions of the world often encounter it. Otomycosis is more prevalent in hot, humid and dusty areas and depends on many climatic conditions (2). This is congruent with present study data, which showed that august to december had the highest prevalence of fungal infections. The present study was carried out in Puducherry Union Territory, India. The density of dust particles in the air has increased in recent years due to several new projects in and around Puducherry city. During the rainy season, there is a high relative humidity of around 70 percent. Compared to other researchers, present study found a lot of fungal otitis externa in tropical and subtropical countries, like India, in the last few decades during the rainy season (3),(4),(5).

In the present study, the age group analysis revealed thatotomycosis could affect any age group from 1-60 years old. However, the incidence was highest at 48 (38.1%) in the age group of 16-30 years, while a small number of patients were reported in the paediatric age group of 0-10 years. Similar to the findings mentioned by Fasunla J et al., and Ologe FE and Nwabuisi C (4),(6). Due to work exposure, travel and other factors, these age groups are more exposed to mycelia than older and younger age groups, which results in a higher incidence in these age groups (7). The present study found that males were more likely to be infected than females, which was consistent with other studies, as males spend more time outdoors, leading to more exposure to fungal spores (5). Present findings were consistent with those of Kaur R et al., and Ho T et al., who reported a 60% and 56% male incidence, respectively (7),(8). Present study found unilateral involvement in 118 (93.65%) patients with predisposing characteristics, which was consistent with the study of Barati B et al., in which unilateral involvement was 97% (9). Ho T et al., reported that 7% of the patients were affected on both sides, which was the same as what present study found: 6.35% of the patients had bilateral otomycosis (8).

According to the literature, itching, ear discharge, ear ache, blocking sensations, decreased hearing and tinnitus were the most common symptoms in all patients with otomycosis (3),(10). In present study, the most common symptoms were 44 (34.92%) itching, followed by 37 (29.37%) pain, 23 (18.25%) ear block, 8 (6.35%) loss of hearing, 9 (7.14%) tinnitus and 5 (3.97%) ear discharge. Similarly, Gupta S and Mahajan B, and Sangavi AKB et al., found itching to be a prevalent presenting symptom in their respective investigations (11),(12). CSOM is one of the most important risk factors for otomycosis. In the present study, CSOM was noted 37 (29.37) followed by CSOM with ear drops 28 (22.22%), DM with CSOM 11 (8.73), bathing in a pond 9 (7.14%), 30 (23.81)% of cases had no predisposing factors, in which present results also correlated with Punia RS et al., showed that 49% of patients had CSOM as a predisposing factor (14), and the usage of antibiotics and steroid ear drops was 21.4%, which also correlated with Prasanna V et al., whose findings showed 56.25% usage of ear drops (15). Interestingly, in present study group, 30 (23.81%) of cases had no predisposing factors in isolates clinically diagnosed with otomycosis. The Agarwal P and Devi LS, study also supports present study that, 32% had no predisposing factors and showed that 42% of fungal isolates were diagnosed with otomycosis (1).

In an overview of the literature, Aspergillus niger and Candida found to be the most common fungal isolates causing otomycosis worldwide, similar to the studies conducted by Agarwal P and Devi LS, Aneja KR et al., and Hagiwara S et al., (1),(16),(17). Among the Aspergillus species, A. niger was the most common isolate, followed by A. flavus, A. terreus, and A. fumigatus. C. albicans 6 (6.52%) was the most common Candida species isolated from otomycosis cases, followed by C. glabrata, and Pencillum. Similar results have been reported previously by Agarwal P and Devi LS, where the authors found Aspergillus spp. 302 (87.3%) to be the predominant fungi isolated from the cases followed by Candida spp. 35 (10%) and Penicillium 2 (0.6%) (1). Gupta S and Mahajan B, in their study, they found A. niger 20 (51.3%), A. flavus 7 (17.9%), A. fumigatus, and Candida spp. 6 (15.4%), to be the most common fungal isolates recovered from clinically suspected cases of otomycosis respectively (11). Likewise, Sangavi AKB et al., have reported A. niger 15 (46.9%) followed by A. flavus 6 (18.8%) and Candida spp. 10 (31.3%) to be the most common fungal isolates were recovered from 32 samples (12). In a study done by Ashopa V et al, Aspergillus species and Candida species were highly isolated fungal pathogens in otomycosis 76 (70.37%) and 17 (15.74%), respectively (18).

In the index study, the susceptibility test disc diffusion met hod was performed against itraconazole, ketoconazole, fluconazole and amphotericin B. Present results showed Aspergillus were more sensitive to amphotericin B, followed by itraconazole, ketoconazole, and fluconazole and two Penicillium isolates were 100% sensitive to amphotericin B and itraconazole these findings were correlated with Kazemi A et al., the study showed, Penicillium is more sensitive to amphotericin B (19). Among 46 isolates, 37 (80.43%) A. niger were sensitive and 9 (19.57%) were resistant to amphotericin B and A. flavus 19 (82.6%) were sensitive to amphotericin B and 4 (17.39%) were resistant, these findings match with Misra R et al., showed amphotericin B are resistant to isolates (20). Similarly, over 23 isolates, 22 (95.7%) of A. flavus were sensitive to itraconazole and 1 (4.3%) was a resistant isolate. Present findings were correlated with Misra R et al., and Karaarslan A et al., studies showed A. flavus were 100% sensitive to amphotericin B and showed no resistance to itraconazole (20),(21). In present study observations among nine Candida species, six were C. albicans, two were C. parapsilosis and one was C. glabrata as identified. Interestingly all nine species of Candida were 100% sensitive to amphotericin B whereas itraconazole, fluconazole showed high resistance to other fungal isolates. In among that C. albicans were more sensitive to ketoconazole (16.7%) compared to other azoles (22). Overall present study finding indicates, a majority of fungi that led to otomycosis were sensitive to amphotericin B, though some were resistant to fluconazole and itraconazole.

Limitation(s)

A limitation of the current study was the small number of cases (n=126). Also, ear swabs were used to get samples, which is not a good way to figure out what kind of otomycosis a person has. There is also a need to study the increase in Minimum Inhibitory Concentration (MIC) values over a period developed by different bacterial isolates in particular geographic locations.

Conclusion

Early microbiological diagnosis and microscopic examination of fungal culture are needed for prompt and effective treatment to avoid severe complications in otomycosis. The present study highlights the increased prevalence of otomycosis in males as compared to females, with the majority of the cases occurring in the rainy season. It was commonly found in people working in dusty environments, particularly agricultural and indoor workers, housewives, and labourers. Further educating and providing proper awareness to the Puducherry rural population and agriculturists is another important concern to be addressed, and the proper identification of fungal agents and host factors involved in otomycosis will improve the outcome for such patients.

Acknowledgement

Authors acknowledge Aarupadai Veedu Medical College and Hospital for providing laboratory facilities and technical assistance.

References

1.
Agarwal P, Devi LS. Otomycosis in a rural community attending a tertiary care hospital: Assessment of risk factors and identification of fungal and bacterial agents. J Clin Diag Res. 2017;11(6):14-18. [crossref] [PubMed]
2.
Pontes ZB, Silva AD, Lima E, de O, Guerra M, de H, et al. Otomycosis; A retrospecttiv study. Brazilian Journal of Otolarygology. 2009;75(3):367-70. [crossref]
3.
Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T, et al., Primary otomycosis in the Indian subcontinent: Predisposing factors, microbiology, and classification. Int J Microbiol. 2014;2014:636493. [crossref] [PubMed]
4.
Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008;51(1):67-70.
5.
Viswanatha B, Sumatha D, Vijayashree MS. Otomycosis in immunocompetent and immunocompromised patients: Comparative study and literature review. Ear Nose Throat J. 2012;91(3):114-21. [crossref] [PubMed]
6.
Ologe FE, Nwabuisi C. Treatment outcome of otomycosis in Ilorin, Nigeria. West African J Med 2002;21(1):34-36.
7.
Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: A clinicomycologic study. Ear Nose Throat J. 2000;79(8):606-09. [crossref] [PubMed]
8.
Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006;135(2):787-91. [crossref] [PubMed]
9.
Barati B, Okhovvat SAR, Goljanian A, Omrani MR. Otomycosis in central iran: A clinical and mycological study. Iran Red Crescent Med J. 2011;13(12):873-76.
10.
Pradhan B, Tuladhar RN, Amatya MR. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Annals of Otology, Rhinology and Laryngology. 2003;112(4):384-87. [crossref] [PubMed]
11.
Gupta S, Mahajan B. Prevalence and demographic profile of patients presenting with otomycosis. JK Science. 2015;17(3):138-42.
12.
Sangavi AKB, Peerapur B, Gummadi N. Clinico-mycological study of otomycosis in Raichur, Karnataka: A hospital based study. Int J Otorhinolaryngol Head Neck Surg. 2018;4(1):133-36. [crossref]
13.
Alastruey-Izquierdo A, Melhem MS, Bonfietti LX, Rodriguez-Tudela JL. Susceptibility test for fungi: Clinical and laboratorial correlations in medical mycology. Rev Inst Med Trop Sao Paulo. 2015;57(Suppl 19):57-64. doi: 10.1590/ S0036-46652015000700011. PMID: 26465371; PMCID: PMC4711191. [crossref] [PubMed]
14.
Punia RS, Singhal SK, Kundu R, Das A, Chander J. Fungal suppurative otitis media (histopathology) among patients in north India. Head Neck Pathol. 2019;13(2):149- 53. Available from: http://dx.doi.org/10.1007/s12105-018-0918-2 [crossref] [PubMed]
15.
Prasanna V, Katiyar VMH, Kannan I. Study of etiological factors, mycological profile and treatment of otomycosis. Int J Med Res Rev. 2014;2(4):355-60. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/117. [crossref]
16.
Aneja KR, Sharma C, Joshi R. Fungal infection of the ear: A common problem in the north eastern part of Haryana. Int J Ped Otorhinolaryngol. 2010;74(6):604-07. [crossref] [PubMed]
17.
Hagiwara S, Tamura T, Satoh K, Kamewada H, Nakano M, Shinden S, et al. The molecular identification and antifungal susceptibilities of Aspergillus species causing otomycosis in Tochigi, Japan. Mycopathologia. 2019;184(1):13-21. [crossref] [PubMed]
18.
Ashopa V, Verma U, Nareda P, Gupta E, prakash P. Assessment of risk factors and microbial profile of otomycosis in patients attending tertiary level hospital of Western Rajasthan, India. J Clin Diag Res. 2020;14(2):DC01-DC04. [crossref]
19.
Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H, et al. Etiologic agents of otomycosis in the North-Western area of Iran. Jundishapur J Microbiol. 2015;8(9). Available from: http://dx.doi.org/10.5812/ jjm.21776. [crossref] [PubMed]
20.
Misra R, Malik A, Singhal S. Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species. Indian J Pathol Microbiol. 2011;54(1):112-16. [crossref] [PubMed]
21.
Karaarslan A, Arikan S, Ozcan M, Ozcan KM. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis. Mycoses. 2004;47(7):284-87. [crossref] [PubMed]
22.
Mímica LMJ, Ueda SMY, Martino MDV, Navarini A, Martini IJ. Candida infection diagnosis: Evaluation of Candida species identification and characterization of susceptibility profile. J Bras Patol Med Lab. 2009;45(1):17-23. [crossref]

DOI and Others

DOI: 10.7860/JCDR/2022/57715.17073

Date of Submission: May 11, 2022
Date of Peer Review: Jun 08, 2022
Date of Acceptance: Aug 16, 2022
Date of Publishing: Oct 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: May 13, 2022
• Manual Googling: Jul 30, 2022
• iThenticate Software: Aug 13, 2022 (17%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com